These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9042312)
1. Axillary dissection can be avoided in selected breast cancer patients: analysis of 401 cases. Greco M; Agresti R; Raselli R; Giovanazzi R; Veronesi U Anticancer Res; 1996; 16(6C):3913-7. PubMed ID: 9042312 [TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature. Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092 [TBL] [Abstract][Full Text] [Related]
3. [Breast-conserving surgery in breast cancer]. Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427 [TBL] [Abstract][Full Text] [Related]
4. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience. Vitucci C; Tirelli C; Graziano F; Santoro E J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819 [TBL] [Abstract][Full Text] [Related]
5. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases. Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921 [TBL] [Abstract][Full Text] [Related]
6. [Results of conservative surgery in T1 breast carcinoma. Our experience in 66 treated cases]. Barillari P; Leuzzi R; Nardi M; Cerasi A; Calcaterra D; Cesareo S; Brandimarte A; Manetti G; Bovino A; Sammartino P Minerva Chir; 1994 Nov; 49(11):1083-8. PubMed ID: 7708228 [TBL] [Abstract][Full Text] [Related]
7. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064 [TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients. Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881 [TBL] [Abstract][Full Text] [Related]
9. Alternative therapy for elderly patients with breast cancer. von Rueden DG; Sessions SC Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979 [TBL] [Abstract][Full Text] [Related]
10. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer. Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740 [TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy in elderly breast cancer patients. Gennari R; Rotmensz N; Perego E; dos Santos G; Veronesi U Surg Oncol; 2004 Dec; 13(4):193-6. PubMed ID: 15615656 [TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
13. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Martelli G; Miceli R; Costa A; Coradini D; Zurrida S; Piromalli D; Vetrella G; Greco M Cancer; 2008 Feb; 112(3):481-8. PubMed ID: 18098268 [TBL] [Abstract][Full Text] [Related]
14. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma. Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012 [TBL] [Abstract][Full Text] [Related]
16. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
17. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results]. Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486 [TBL] [Abstract][Full Text] [Related]
18. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092 [TBL] [Abstract][Full Text] [Related]
19. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770 [TBL] [Abstract][Full Text] [Related]
20. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Barth A; Craig PH; Silverstein MJ Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]